May increase efficacy of GBM treatmentsNon-toxic to healthy cells; reduces comorbiditiesTargets slow-dividing stem cells as opposed to rapid-dividing cells (i.e. chemotherapies)
[Detail]
-Increase of 30-40% in efficiency over current technologies-Energy Storage-Low capital costs
[Detail]
Feature selection and tracking are performed in real-time Improved baseline algorithms in terms of performance accuracy and robustness Lower computational costs
[Detail]
Efficient therapy to treat hormone resistant tumorSelective inhibition of prostate cancer cellsProvides a specific drug target against an extremely difficult-to-treat cancerExtensive cancerous cell death upon administration
[Detail]
| |< <- | [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] | -> >| |
